LataMed AI is trading at $0.05, down 18.00%, amid a broad risk-off session, the likeliest available context, though direct causation is unconfirmed. - No new company-specific announcement was identified for October 22; the previously reported healthcare cooperation agreement is not a fresh catalyst. - Reuters reported U.S. stock futures lower as renewed AI-spending concerns and rising oil prices linked to Middle East tensions weighed on sentiment. - Live price was supplied; volume information is unavailable.